Sign in
4

Changes in Ownership

Jasper Therapeutics, Inc. Filed Acc 0001213900-23-007992

Options or other derivatives

  • President, CEO & Director acquired 1,093,831 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

MARTELL RON · President, CEO & Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-02-02 Grant or award : show line 1 in the form Stock Option (right to buy) +1,093,831 1,093,831 D
Loading xslF345X03/ownership.xml…